marketcaparena
Search

    VRTX

    VERTEX PHARMACEUTICALS INC / MA

    Company overview

    Market capitalization
    $133.74B
    Employees
    6,400
    Latest publication
    2026-09-29
    About VERTEX PHARMACEUTICALS INC / MA

    Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD), transfusion dependent beta thalassemia (TDT), and acute pain. It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The company also develops CASGEVY for the treatment of SCD and TDT; JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA therapeutic designed to treat the underlying cause of CF, which is in Phase 1/2 clinical trial; inaxaplin for the treatment of APOL1-mediated kidney disease, which is in single Phase 2 trial; VX-264 for treating Type 1 Diabetes; VX-670 for the treatment of myotonic dystrophy type 1; and VX-407, a small molecule corrector for the treatment of autosomal dominant polycystic kidney disease. The company sells its products primarily to specialty pharmacy and distributors, wholesalers, retail pharmacies, hospitals, and clinics. Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue3,333,900,000USD2,986,900,000USD3,227,100,000USD3,076,400,000USD2,964,700,000USD2,770,200,000USD2,912,000,000USD2,771,900,000USD
    Cost Of Revenue489,200,000USD392,800,000USD466,000,000USD414,800,000USD407,500,000USD363,000,000USD423,400,000USD392,600,000USD
    Gross Profit2,844,700,000USD2,594,100,000USD2,761,100,000USD2,661,600,000USD2,557,200,000USD2,407,200,000USD2,488,600,000USD2,379,300,000USD
    Research Development993,800,000USD961,600,000USD973,700,000USD1,032,200,000USD978,400,000USD979,700,000USD998,700,000USD875,900,000USD
    Selling General Administrative582,200,000USD493,700,000USD487,000,000USD445,100,000USD424,600,000USD396,400,000USD377,600,000USD371,800,000USD
    Other Operating Expenses21,800,000USD———————
    Total Operating Expenses1,597,800,000USD1,456,000,000USD1,460,700,000USD1,475,400,000USD1,406,100,000USD1,777,100,000USD1,462,600,000USD1,263,000,000USD
    Operating Income1,246,900,000USD1,138,100,000USD1,300,400,000USD1,186,200,000USD1,151,100,000USD630,100,000USD1,026,000,000USD1,116,300,000USD
    Total Other Income Expense Net144,900,000USD114,800,000USD30,600,000USD112,600,000USD131,900,000USD100,300,000USD110,500,000USD107,800,000USD
    Depreciation And Amortization56,500,000USD—53,100,000USD54,000,000USD51,700,000USD48,400,000USD46,500,000USD53,200,000USD
    Income Before Tax1,391,800,000USD1,252,900,000USD1,331,000,000USD1,298,800,000USD1,283,000,000USD730,400,000USD1,136,500,000USD1,224,100,000USD
    Income Tax Expense292,000,000USD221,500,000USD139,900,000USD215,900,000USD250,100,000USD84,100,000USD223,500,000USD178,700,000USD
    Net Income1,099,800,000USD1,031,400,000USD1,191,100,000USD1,082,900,000USD1,032,900,000USD646,300,000USD913,000,000USD1,045,400,000USD
    Interest Income——121,900,000USD125,700,000USD122,400,000USD120,900,000USD128,200,000USD132,200,000USD
    Interest Expense——3,300,000USD3,300,000USD3,700,000USD3,000,000USD2,800,000USD7,500,000USD
    Net Interest Income——118,600,000USD122,400,000USD118,700,000USD117,900,000USD125,400,000USD124,700,000USD
    Tax Provision——139,900,000USD215,900,000USD250,100,000USD84,100,000USD223,500,000USD178,700,000USD
    Net Income From Continuing Ops——1,191,100,000USD1,082,900,000USD1,032,900,000USD646,300,000USD913,000,000USD1,045,400,000USD
    Ebit——1,334,300,000USD1,302,100,000USD1,286,700,000USD733,400,000USD1,137,900,000USD1,231,600,000USD
    Ebitda——1,387,400,000USD1,356,100,000USD1,338,400,000USD781,800,000USD1,184,400,000USD1,284,800,000USD
    Reconciled Depreciation——55,700,000USD54,000,000USD51,700,000USD48,400,000USD46,500,000USD53,200,000USD
    Unclassified Operating Expenses—————401,000,000USD86,300,000USD15,300,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Total Revenue6,320,800,000USD
    Cost Of Revenue882,000,000USD
    Gross Profit5,438,800,000USD
    Research Development1,955,400,000USD
    Selling General Administrative1,075,900,000USD
    Other Operating Expenses22,500,000USD
    Total Operating Expenses3,053,800,000USD
    Operating Income2,385,000,000USD
    Total Other Income Expense Net259,700,000USD
    Depreciation And Amortization112,400,000USD
    Income Before Tax2,644,700,000USD
    Income Tax Expense513,500,000USD
    Net Income2,131,200,000USD
    SourceDisclosureDeterministicFinal

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USDFY 19991999-12-31 · USD
    Total Revenue12,074,600,000USD9,869,200,000USD8,930,700,000USD7,574,400,000USD6,205,683,000USD4,162,821,000USD3,047,597,000USD61,600,000USD
    Cost Of Revenue1,807,100,000USD1,262,200,000USD1,080,300,000USD904,200,000USD736,300,000USD547,758,000USD409,539,000USD-3,400,000USD
    Gross Profit10,267,500,000USD8,607,000,000USD7,850,400,000USD6,670,200,000USD5,469,383,000USD3,615,063,000USD2,638,058,000USD65,000,000USD
    Research Development3,753,700,000USD3,162,900,000USD2,655,800,000USD3,051,100,000USD1,829,537,000USD1,754,540,000USD1,416,476,000USD72,200,000USD
    Selling General Administrative1,753,100,000USD1,136,600,000USD887,200,000USD840,100,000USD770,456,000USD658,498,000USD557,616,000USD26,100,000USD
    Total Operating Expenses5,506,800,000USD4,775,000,000USD3,543,000,000USD3,891,200,000USD2,613,100,000USD2,413,038,000USD1,974,092,000USD104,600,000USD
    Operating Income4,760,700,000USD3,832,000,000USD4,307,400,000USD2,782,100,000USD2,856,300,000USD1,197,566,000USD635,150,000USD-39,600,000USD
    Interest Income490,900,000USD614,700,000USD144,600,000USD4,900,000USD22,239,000USD63,678,000USD33,496,000USD—
    Interest Expense13,300,000USD44,100,000USD54,800,000USD61,500,000USD58,151,000USD58,502,000USD34,119,000USD0USD
    Net Interest Income477,600,000USD570,600,000USD89,800,000USD-56,600,000USD-35,912,000USD5,176,000USD-34,119,000USD—
    Income Before Tax4,643,200,000USD4,379,800,000USD4,232,400,000USD2,730,400,000USD3,116,900,000USD1,394,919,000USD600,241,000USD-40,300,000USD
    Income Tax Expense690,000,000USD760,200,000USD910,400,000USD388,300,000USD405,151,000USD218,109,000USD-1,486,862,000USD1,400,000USD
    Tax Provision690,000,000USD760,200,000USD910,400,000USD388,300,000USD405,151,000USD218,109,000USD-1,486,862,000USD—
    Net Income3,953,200,000USD3,619,600,000USD3,322,000,000USD2,342,100,000USD2,711,700,000USD1,176,810,000USD2,096,896,000USD-41,000,000USD
    Net Income From Continuing Ops3,953,200,000USD3,619,600,000USD3,322,000,000USD2,342,100,000USD2,711,647,000USD1,176,810,000USD2,087,103,000USD—
    Ebit4,656,500,000USD4,423,900,000USD4,287,200,000USD2,791,900,000USD3,174,949,000USD1,453,421,000USD634,360,000USD-50,600,000USD
    Ebitda4,863,700,000USD4,605,200,000USD4,435,500,000USD2,917,500,000USD3,284,464,000USD1,560,362,000USD706,780,000USD-44,300,000USD
    Depreciation And Amortization207,200,000USD181,300,000USD148,300,000USD125,600,000USD109,515,000USD106,941,000USD72,420,000USD6,300,000USD
    Reconciled Depreciation209,800,000USD181,300,000USD148,300,000USD125,600,000USD109,515,000USD106,941,000USD72,420,000USD—
    Total Other Income Expense Net-117,500,000USD547,800,000USD-75,000,000USD-51,700,000USD260,600,000USD197,419,000USD-34,909,000USD10,300,000USD
    Unclassified Operating Expenses—475,500,000USD—————6,300,000USD
    Non Operating Income Net Other——-20,200,000USD9,800,000USD318,659,000USD255,855,000USD-790,000USD—
    Net Income Applicable To Common Shares——3,322,000,000USD2,342,100,000USD2,711,647,000USD1,176,810,000USD2,096,896,000USD—
    Minority Interest————0USD0USD-9,793,000USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets27,423,300,000USD26,484,400,000USD26,142,800,000USD24,862,300,000USD24,036,700,000USD22,880,500,000USD22,533,200,000USD22,240,200,000USD
    Cash And Equivalents6,143,500,000USD5,492,900,000USD——————
    Cash And Short Term Investments7,852,400,000USD7,246,700,000USD6,611,100,000USD6,287,000,000USD6,382,800,000USD6,201,200,000USD6,115,900,000USD6,524,500,000USD
    Short Term Investments1,708,900,000USD1,753,800,000USD1,523,300,000USD1,347,400,000USD1,410,600,000USD1,526,500,000USD1,546,300,000USD1,285,300,000USD
    Long Term Investments5,789,100,000USD5,749,900,000USD5,712,300,000USD5,722,800,000USD5,645,900,000USD5,156,500,000USD5,107,900,000USD4,703,500,000USD
    Total Current Assets12,543,700,000USD11,730,300,000USD11,201,000,000USD10,569,600,000USD10,427,900,000USD10,008,800,000USD9,596,400,000USD9,804,100,000USD
    Other Current Assets791,900,000USD720,800,000USD850,300,000USD709,400,000USD652,300,000USD642,800,000USD665,700,000USD449,200,000USD
    Other Non Current Assets1,250,900,000USD1,256,400,000USD——————
    Total Liabilities7,175,400,000USD7,122,500,000USD——————
    Total Current Liabilities3,937,900,000USD3,880,600,000USD3,861,200,000USD4,475,300,000USD4,138,400,000USD3,783,200,000USD3,564,600,000USD3,973,100,000USD
    Other Current Liabilities329,400,000USD407,100,000USD——————
    Other Non Current Liabilities1,259,900,000USD1,255,400,000USD——————
    Total Stockholder Equity20,247,900,000USD19,361,900,000USD18,665,800,000USD17,318,800,000USD17,175,400,000USD16,496,300,000USD16,409,600,000USD15,630,900,000USD
    Total Equity Including Noncontrolling Interest20,247,900,000USD19,361,900,000USD——————
    Net Receivables2,134,300,000USD1,996,100,000USD2,052,800,000USD1,946,400,000USD1,893,500,000USD1,805,100,000USD1,609,400,000USD1,750,600,000USD
    Inventory1,765,100,000USD1,766,700,000USD1,686,800,000USD1,626,800,000USD1,499,300,000USD1,359,700,000USD1,205,400,000USD1,079,800,000USD
    Property Plant Equipment Net3,327,900,000USD3,293,500,000USD3,083,000,000USD3,016,900,000USD2,648,900,000USD2,634,400,000USD2,584,600,000USD2,513,900,000USD
    Goodwill1,088,000,000USD1,088,000,000USD——————
    Intangible Assets412,800,000USD418,500,000USD424,200,000USD429,800,000USD435,500,000USD441,200,000USD825,900,000USD831,600,000USD
    Accounts Payable429,500,000USD489,300,000USD461,700,000USD420,300,000USD442,300,000USD445,000,000USD413,000,000USD395,800,000USD
    Common Stock2,500,000USD2,500,000USD2,500,000USD2,500,000USD2,600,000USD2,600,000USD2,600,000USD2,600,000USD
    Retained Earnings15,691,200,000USD14,591,400,000USD13,560,000,000USD12,368,900,000USD11,286,000,000USD10,253,100,000USD9,606,800,000USD8,693,800,000USD
    Accumulated Other Comprehensive Income48,500,000USD24,800,000USD-15,900,000USD-64,500,000USD-101,100,000USD68,100,000USD127,800,000USD28,800,000USD
    Total Liab——7,477,000,000USD7,543,500,000USD6,861,300,000USD6,384,200,000USD6,123,600,000USD6,609,300,000USD
    Other Current Liab——3,144,900,000USD4,055,000,000USD3,696,100,000USD3,338,200,000USD2,691,400,000USD3,577,300,000USD
    Capital Stock——2,500,000USD2,500,000USD2,600,000USD2,600,000USD2,600,000USD2,600,000USD
    Good Will——1,088,000,000USD1,088,000,000USD1,088,000,000USD1,088,000,000USD1,088,000,000USD1,088,000,000USD
    Cash——5,087,800,000USD4,939,600,000USD4,972,200,000USD4,674,700,000USD4,569,600,000USD5,239,200,000USD
    Current Deferred Revenue——171,800,000USD———206,800,000USD220,000,000USD
    Net Debt——-1,205,300,000USD-3,104,800,000USD-3,444,800,000USD-3,025,600,000USD-2,820,100,000USD-3,536,300,000USD
    Short Term Debt——82,800,000USD———92,300,000USD-220,000,000USD
    Short Long Term Debt Total——3,882,500,000USD1,834,800,000USD1,527,400,000USD1,649,100,000USD1,749,500,000USD1,702,900,000USD
    Property Plant Equipment Gross——4,287,100,000USD3,016,900,000USD2,648,900,000USD2,634,400,000USD3,649,400,000USD2,513,900,000USD
    Common Stock Shares Outstanding——256,100,000shares257,600,000shares258,900,000shares259,500,000shares260,500,000shares261,000,000shares
    Non Current Assets Total——14,941,800,000USD14,292,700,000USD13,608,800,000USD12,871,700,000USD12,936,800,000USD12,436,100,000USD
    Non Current Liabilities Total——3,615,800,000USD3,068,200,000USD2,722,900,000USD2,601,000,000USD2,559,000,000USD2,636,200,000USD
    Non Current Liabilities Other——267,400,000USD1,233,400,000USD1,195,500,000USD951,900,000USD203,200,000USD933,300,000USD
    Non Currrent Assets Other——1,142,400,000USD1,098,000,000USD1,078,800,000USD1,007,300,000USD999,300,000USD990,200,000USD
    Net Working Capital——7,339,800,000USD6,094,300,000USD6,289,500,000USD6,225,600,000USD6,031,800,000USD5,831,000,000USD
    Unclassified Non Current Assets——3,491,900,000USD2,937,200,000USD2,711,700,000USD2,544,300,000USD2,331,100,000USD2,308,900,000USD
    Unclassified Non Current Liabilities——3,348,400,000USD1,834,800,000USD1,527,400,000USD1,649,100,000USD2,355,800,000USD1,702,900,000USD
    Unclassified Equity——5,116,700,000USD5,009,400,000USD5,985,300,000USD6,169,900,000USD6,669,800,000USD6,903,100,000USD
    Unclassified Current Liabilities——————161,100,000USD-220,000,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets26,142,800,000USD22,533,200,000USD22,730,200,000USD18,150,900,000USD13,432,500,000USD11,751,808,000USD8,318,465,000USD6,245,898,000USD
    Intangible Assets424,200,000USD825,900,000USD839,900,000USD603,600,000USD400,000,000USD400,000,000USD400,000,000USD50,384,000USD
    Other Current Assets850,300,000USD665,700,000USD623,700,000USD553,500,000USD545,800,000USD308,323,000USD213,515,000USD74,045,000USD
    Total Liab7,477,000,000USD6,123,600,000USD5,149,800,000USD4,238,200,000USD3,332,500,000USD3,065,000,000USD2,233,221,000USD1,810,695,000USD
    Total Stockholder Equity18,665,800,000USD16,409,600,000USD17,580,400,000USD13,912,700,000USD10,100,000,000USD8,686,800,000USD6,085,244,000USD4,435,203,000USD
    Other Current Liab3,144,900,000USD2,691,400,000USD2,829,000,000USD2,065,900,000USD1,483,800,000USD1,384,327,000USD1,073,798,000USD40,589,000USD
    Common Stock2,500,000USD2,600,000USD2,600,000USD2,600,000USD2,500,000USD2,599,000USD2,589,000USD2,546,000USD
    Capital Stock2,500,000USD2,600,000USD2,600,000USD2,600,000USD2,500,000USD2,599,000USD2,589,000USD2,546,000USD
    Retained Earnings13,560,000,000USD9,606,800,000USD10,142,400,000USD6,522,800,000USD3,200,800,000USD858,669,000USD-1,852,978,000USD-2,989,478,000USD
    Good Will1,088,000,000USD1,088,000,000USD1,088,000,000USD1,088,000,000USD1,002,200,000USD1,002,200,000USD1,002,158,000USD50,384,000USD
    Cash5,087,800,000USD4,569,600,000USD10,369,100,000USD10,504,000,000USD6,795,000,000USD5,988,200,000USD3,109,322,000USD2,650,134,000USD
    Cash And Short Term Investments6,611,100,000USD6,115,900,000USD11,218,300,000USD10,778,500,000USD7,524,900,000USD6,658,900,000USD3,808,294,000USD3,168,242,000USD
    Total Current Assets11,201,000,000USD9,596,400,000USD14,144,200,000USD13,234,800,000USD9,560,600,000USD8,133,400,000USD4,822,829,000USD3,702,290,000USD
    Total Current Liabilities3,861,200,000USD3,564,600,000USD3,547,400,000USD2,742,100,000USD2,142,000,000USD1,877,500,000USD1,334,827,000USD715,482,000USD
    Current Deferred Revenue171,800,000USD206,800,000USD170,300,000USD159,600,000USD171,700,000USD191,500,000USD62,332,000USD554,089,000USD
    Net Debt-1,205,300,000USD-2,820,100,000USD-9,560,700,000USD-9,604,300,000USD-5,827,600,000USD-5,056,300,000USD-2,447,660,000USD-2,082,971,000USD
    Short Term Debt82,800,000USD92,300,000USD83,700,000USD89,400,000USD80,200,000USD42,400,000USD38,794,000USD9,817,000USD
    Short Long Term Debt Total3,882,500,000USD1,749,500,000USD808,400,000USD899,700,000USD967,400,000USD931,900,000USD661,662,000USD591,367,000USD
    Long Term Investments5,712,300,000USD5,107,900,000USD2,497,800,000USD112,200,000USD——60,800,000USD13,600,000USD
    Short Term Investments1,523,300,000USD1,546,300,000USD849,200,000USD274,500,000USD729,900,000USD670,700,000USD698,972,000USD518,108,000USD
    Net Receivables2,052,800,000USD1,609,400,000USD1,563,400,000USD1,442,200,000USD1,136,800,000USD885,400,000USD633,518,000USD409,688,000USD
    Inventory1,686,800,000USD1,205,400,000USD738,800,000USD460,600,000USD353,100,000USD280,777,000USD167,502,000USD124,360,000USD
    Accounts Payable461,700,000USD413,000,000USD364,900,000USD303,900,000USD195,000,000USD155,100,000USD87,610,000USD110,987,000USD
    Property Plant Equipment Net3,083,000,000USD2,584,600,000USD1,452,900,000USD1,455,800,000USD1,424,400,000USD1,284,100,000USD833,282,000USD812,005,000USD
    Property Plant Equipment Gross4,287,100,000USD3,649,400,000USD2,641,800,000USD2,483,100,000USD2,320,400,000USD958,534,000USD745,080,000USD812,005,000USD
    Accumulated Other Comprehensive Income-15,900,000USD127,800,000USD-14,300,000USD800,000USD15,900,000USD-68,480,000USD-1,973,000USD659,000USD
    Common Stock Shares Outstanding258,000,000shares257,900,000shares260,500,000shares259,100,000shares259,899,999shares263,396,000shares260,673,000shares259,185,000shares
    Non Current Assets Total14,941,800,000USD12,936,800,000USD8,586,000,000USD4,916,100,000USD3,871,900,000USD3,618,400,000USD3,495,636,000USD2,543,608,000USD
    Non Current Liabilities Total3,615,800,000USD2,559,000,000USD1,602,400,000USD1,496,100,000USD1,190,500,000USD1,187,500,000USD898,394,000USD1,095,213,000USD
    Non Current Liabilities Other267,400,000USD203,200,000USD196,300,000USD1,496,100,000USD902,200,000USD1,187,460,000USD898,394,000USD108,853,000USD
    Non Currrent Assets Other1,142,400,000USD999,300,000USD895,300,000USD409,600,000USD110,800,000USD49,300,000USD69,381,000USD181,547,000USD
    Net Working Capital7,339,800,000USD6,031,800,000USD10,596,800,000USD10,250,700,000USD7,141,200,000USD6,255,846,000USD3,488,002,000USD2,722,817,000USD
    Unclassified Non Current Assets3,491,900,000USD2,331,100,000USD1,812,100,000USD-175,800,000USD-52,400,000USD295,773,000USD-69,381,000USD-104,712,000USD
    Unclassified Non Current Liabilities3,348,400,000USD2,355,800,000USD1,406,100,000USD-685,800,000USD-613,900,000USD-923,367,000USD-275,526,000USD315,615,000USD
    Unclassified Equity5,116,700,000USD6,669,800,000USD7,447,100,000USD7,383,900,000USD6,878,300,000USD7,891,413,000USD7,935,017,000USD7,418,930,000USD
    Unclassified Current Liabilities—161,100,000USD99,500,000USD123,300,000USD211,300,000USD104,173,000USD72,293,000USD—
    Other Liab———685,800,000USD902,200,000USD923,407,000USD275,526,000USD108,853,000USD
    Other Assets———1,422,700,000USD986,900,000USD587,027,000USD1,199,396,000USD1,540,400,000USD
    Net Tangible Assets———12,221,100,000USD8,697,800,000USD7,284,657,000USD4,683,086,000USD4,384,819,000USD
    Long Term Debt———————561,892,000USD
    Unclassified Current Assets———————-74,045,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Net Income2,131,200,000USD
    Depreciation112,400,000USD
    Stock Based Compensation336,600,000USD
    Deferred Income Tax-135,000,000USD
    Other Non Cash Items-21,400,000USD
    Change To Account Receivables-100,400,000USD
    Change To Inventory-125,400,000USD
    Change To Liabilities233,500,000USD
    Change In Working Capital129,700,000USD
    Operating Cash Flow2,553,500,000USD
    Capital Expenditures-245,600,000USD
    Net Investments-305,900,000USD
    Other Investing Activities-1,700,000USD
    Unclassified Investing Cash Flow75,500,000USD
    Investing Cash Flow-477,700,000USD
    Common Stock Issuance74,700,000USD
    Net Common Stock Issuance-1,039,200,000USD
    Other Financing Activities-1,000,000USD
    Financing Cash Flow-965,500,000USD
    Effect Of Forex Changes On Cash-44,000,000USD
    Change In Cash1,066,300,000USD
    End Cash Flow6,154,100,000USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Depreciation55,900,000USD55,700,000USD54,000,000USD51,700,000USD48,400,000USD46,500,000USD53,200,000USD54,000,000USD
    Stock Based Compensation166,400,000USD157,600,000USD194,899,999USD167,300,000USD166,100,000USD167,800,000USD184,600,000USD154,200,000USD
    Other Non Cash Items5,000,000USD10,900,000USD-4,099,999USD67,400,000USD418,200,000USD-34,100,000USD52,400,000USD-8,000,000USD
    Change To Account Receivables39,800,000USD-99,400,000USD-59,900,000USD-18,400,000USD-169,600,000USD69,000,000USD-51,800,000USD135,100,000USD
    Change To Inventory-97,700,000USD-77,400,000USD-131,100,000USD-148,600,000USD-167,100,000USD-147,500,000USD-182,500,000USD-107,200,000USD
    Change To Liabilities129,200,000USD———————
    Change In Working Capital174,200,000USD-947,800,000USD149,600,000USD-132,400,000USD-268,500,000USD-560,200,000USD157,500,000USD-241,400,000USD
    Operating Cash Flow1,428,100,000USD———————
    Capital Expenditures-133,400,000USD-149,400,000USD-101,800,000USD-145,700,000USD-40,700,000USD-92,600,000USD-67,700,000USD-76,700,000USD
    Net Investments-298,500,000USD———————
    Other Investing Activities0USD———————
    Investing Cash Flow-431,900,000USD———————
    Common Stock Issuance27,000,000USD———————
    Net Common Stock Issuance-565,400,000USD———————
    Other Financing Activities-400,000USD———————
    Financing Cash Flow-538,800,000USD———————
    Effect Of Forex Changes On Cash-40,300,000USD———————
    Change In Cash417,100,000USD140,000,000USD-34,200,000USD296,600,000USD113,200,000USD-675,900,000USD657,100,000USD-4,578,400,000USD
    End Cash Flow5,504,900,000USD———————
    Net Income—1,191,100,000USD1,082,900,000USD1,032,900,000USD646,300,000USD913,000,000USD1,045,400,000USD-3,593,600,000USD
    Total Cash From Operating Activities—498,000,000USD1,241,400,000USD1,073,100,000USD818,900,000USD584,600,000USD1,369,800,000USD-3,753,600,000USD
    Free Cash Flow—348,600,000USD1,139,600,000USD927,400,000USD778,200,000USD492,000,000USD1,302,100,000USD-3,830,300,000USD
    Investments—-122,800,000USD-117,000,000USD-484,500,000USD-55,800,000USD-821,900,000USD-348,000,000USD-463,700,000USD
    Total Cashflows From Investing Activities—-288,100,000USD-117,000,000USD-484,500,000USD-55,800,000USD-821,900,000USD-348,000,000USD-463,700,000USD
    Net Borrowings—-1,400,000USD-1,400,000USD-1,300,000USD-1,300,000USD-1,300,000USD-5,400,000USD—
    Total Cash From Financing Activities—-77,200,000USD-1,154,500,000USD-349,200,000USD-680,400,000USD-391,300,000USD-387,500,000USD-358,600,000USD
    Sale Purchase Of Stock—-130,900,000USD-1,071,099,999USD-391,800,000USD-426,100,000USD-417,900,000USD-307,700,000USD-320,300,000USD
    Begin Period Cash Flow—4,947,800,000USD4,982,000,000USD4,685,400,000USD4,572,200,000USD5,248,100,000USD4,580,100,000USD9,169,400,000USD
    End Period Cash Flow—5,087,800,000USD4,947,800,000USD4,982,000,000USD4,685,400,000USD4,572,200,000USD5,248,100,000USD4,580,100,000USD
    Other Cashflows From Investing Activities—-15,900,000USD800,000USD-4,300,000USD-5,300,000USD-30,900,000USD-266,100,000USD-22,700,000USD
    Other Cashflows From Financing Activities—1,100,000USD-89,900,000USD-5,200,000USD-269,700,000USD-6,400,000USD-82,800,000USD-79,600,000USD
    Unclassified Operating Cash Flow—30,500,000USD-235,900,000USD-113,800,000USD-191,600,000USD51,600,000USD-123,300,000USD-118,800,000USD
    Unclassified Financing Cash Flow—54,000,000USD—49,100,000USD16,700,000USD34,300,000USD8,400,000USD41,300,000USD
    Unclassified Investing Cash Flow——101,000,000USD150,000,000USD46,000,000USD123,500,000USD333,800,000USD99,400,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income3,953,200,000USD-535,600,000USD3,619,600,000USD3,322,000,000USD2,342,100,000USD2,711,647,000USD1,176,810,000USD2,087,103,000USD
    Depreciation209,800,000USD207,200,000USD181,300,000USD148,300,000USD125,600,000USD109,515,000USD106,941,000USD72,420,000USD
    Stock Based Compensation685,900,000USD698,500,000USD581,200,000USD491,300,000USD441,400,000USD429,461,000USD360,489,000USD325,047,000USD
    Other Non Cash Items492,400,000USD900,000USD-42,600,000USD103,400,000USD-5,800,000USD-220,005,000USD-176,196,000USD60,021,000USD
    Change To Account Receivables-347,300,000USD-99,300,000USD-84,100,000USD-358,600,000USD-274,700,000USD-223,444,000USD-225,587,000USD-108,152,000USD
    Change To Inventory-524,200,000USD-517,300,000USD-322,900,000USD-136,400,000USD-92,800,000USD-132,014,000USD-64,047,000USD-31,965,000USD
    Change In Working Capital-1,199,100,000USD-514,800,000USD-265,700,000USD340,800,000USD-105,200,000USD-54,454,000USD-66,101,000USD238,020,000USD
    Total Cash From Operating Activities3,631,400,000USD-492,600,000USD3,537,300,000USD4,129,900,000USD2,643,500,000USD3,253,505,000USD1,569,330,000USD1,270,286,000USD
    Capital Expenditures-437,600,000USD-297,700,000USD-258,400,000USD-204,700,000USD-235,000,000USD-259,800,000USD-75,451,000USD-95,524,000USD
    Free Cash Flow3,193,800,000USD-790,300,000USD3,278,900,000USD3,925,200,000USD2,408,500,000USD2,993,705,000USD1,493,879,000USD1,174,762,000USD
    Investments-483,100,000USD-3,770,000,000USD-2,079,600,000USD227,300,000USD-28,900,000USD378,513,000USD33,664,000USD-15,342,000USD
    Total Cashflows From Investing Activities-945,400,000USD-3,770,000,000USD-3,141,700,000USD-321,100,000USD-340,900,000USD99,388,000USD-1,235,318,000USD-202,158,000USD
    Net Borrowings-5,400,000USD-33,600,000USD-44,900,000USD-85,500,000USD-24,400,000USD-29,024,000USD-35,005,000USD-7,086,000USD
    Total Cash From Financing Activities-2,261,300,000USD-1,494,900,000USD-562,200,000USD-67,700,000USD-1,478,000,000USD-505,281,000USD126,773,000USD-71,219,000USD
    Sale Purchase Of Stock-2,017,400,000USD-1,177,100,000USD-427,600,000USD-172,000,000USD-1,561,300,000USD-739,407,000USD-192,015,000USD-350,043,000USD
    Change In Cash515,600,000USD-5,800,100,000USD-139,700,000USD3,711,900,000USD811,200,000USD2,868,164,000USD462,428,000USD990,727,000USD
    Begin Period Cash Flow4,572,200,000USD10,372,300,000USD10,512,000,000USD6,800,100,000USD5,988,900,000USD3,120,681,000USD2,658,253,000USD1,667,526,000USD
    End Period Cash Flow5,087,800,000USD4,572,200,000USD10,372,300,000USD10,512,000,000USD6,800,100,000USD5,988,845,000USD3,120,681,000USD2,658,253,000USD
    Other Cashflows From Investing Activities-24,700,000USD-241,700,000USD-89,000,000USD-47,800,000USD-77,000,000USD-19,327,000USD-1,193,531,000USD-22,821,000USD
    Other Cashflows From Financing Activities-366,200,000USD-398,800,000USD-224,300,000USD3,500,000USD130,300,000USD276,401,000USD24,775,000USD2,079,000USD
    Unclassified Operating Cash Flow-510,800,000USD-348,800,000USD-536,500,000USD-275,900,000USD-154,600,000USD277,341,000USD167,387,000USD-1,512,325,000USD
    Unclassified Financing Cash Flow127,700,000USD114,600,000USD134,600,000USD186,300,000USD79,400,000USD251,695,000USD339,064,000USD304,671,000USD
    Unclassified Investing Cash Flow—539,400,000USD-714,700,000USD-295,900,000USD———-68,471,000USD
    Change To Liabilities———1,162,200,000USD354,100,000USD598,566,000USD188,093,000USD232,177,000USD
    Cash And Cash Equivalents Changes———3,741,100,000USD824,600,000USD2,847,612,000USD460,785,000USD990,727,000USD
    Dividends Paid————-102,000,000USD-264,946,000USD-10,046,000USD-20,840,000USD
    Issuance Of Capital Stock——————343,244,000USD289,293,000USD
    Exchange Rate Changes———————-6,182,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    ALYFTREK Reimbursed Countries

    Period endPeriodValueUnitSource
    2026-06-30instant25countriesDisclosure

    JOURNAVX Individuals With Reimbursed Access

    Period endPeriodValueUnitSource
    2026-06-30instant260,000,000individualsDisclosure

    JOURNAVX Medicaid States With Coverage

    Period endPeriodValueUnitSource
    2026-06-30instant23statesDisclosure

    JOURNAVX Medicare Part D PBMs With Reimbursed Access

    Period endPeriodValueUnitSource
    2026-06-30instant3pharmacy_benefit_managersDisclosure

    JOURNAVX Prescriptions Filled

    Period endPeriodValueUnitSource
    2026-06-30quarterly535,000prescriptionsDisclosure

    JOURNAVX Prescriptions Filled Year to Date

    Period endPeriodValueUnitSource
    2026-06-30year_to_date900,000prescriptionsDisclosure

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductCASGEVY76,400,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductCollaborativeand Royalty0USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductCystic Fibrosis Products — ALYFTREK573,600,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductCystic Fibrosis Products — Manufactured Product Other137,100,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductCystic Fibrosis Products — TRIKAFTAKAFTRIO2,497,200,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductJOURNAVX49,600,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductCASGEVY42,900,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductCollaborativeand Royalty0USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductCystic Fibrosis Products — ALYFTREK424,400,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductCystic Fibrosis Products — Manufactured Product Other135,900,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductCystic Fibrosis Products — TRIKAFTAKAFTRIO2,354,700,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31ProductJOURNAVX29,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductALYFTREK0USDDisclosure
    FY 2024Yearly · 2024-12-31ProductCASGEVY10,000,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductCollaborativeand Royalty0USDDisclosure
    FY 2024Yearly · 2024-12-31ProductJOURNAVX0USDDisclosure
    FY 2024Yearly · 2024-12-31ProductManufactured Product Other781,500,000USDDisclosure
    FY 2024Yearly · 2024-12-31ProductTRIKAFTAKAFTRIO10,238,600,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductALYFTREK0USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductCASGEVY2,000,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductCollaborativeand Royalty0USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductJOURNAVX0USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductManufactured Product Other186,900,000USDDisclosure
    Q3 2024Quarterly · 2024-09-30ProductTRIKAFTAKAFTRIO2,585,000,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductALYFTREK0USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductCASGEVY0USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductCollaborativeand Royalty0USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductJOURNAVX0USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductManufactured Product Other196,400,000USDDisclosure
    Q2 2024Quarterly · 2024-06-30ProductTRIKAFTAKAFTRIO2,449,200,000USDDisclosure
    Q1 2024Quarterly · 2024-03-31ProductALYFTREK0USDDisclosure
    Q1 2024Quarterly · 2024-03-31ProductCASGEVYAnd JOURNAVX0USDDisclosure
    Q1 2024Quarterly · 2024-03-31ProductCollaborativeand Royalty0USDDisclosure
    Q1 2024Quarterly · 2024-03-31ProductManufactured Product Other207,000,000USDDisclosure
    Q1 2024Quarterly · 2024-03-31ProductTRIKAFTAKAFTRIO2,483,600,000USDDisclosure
    Q4 2023Quarterly · 2023-12-31ProductKalydeco112,400,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductORKAMBI44,200,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductSYMDEKOSYMKEVI27,800,000USDLegacy provider
    Q4 2023Quarterly · 2023-12-31ProductTRIKAFTAKAFTRIO2,333,300,000USDLegacy provider
    FY 2023Yearly · 2023-12-31ProductCollaborativeand Royalty0USD0000875320-24-000062
    FY 2023Yearly · 2023-12-31ProductKalydeco475,500,000USD0000875320-24-000062
    FY 2023Yearly · 2023-12-31ProductORKAMBI326,000,000USD0000875320-24-000062
    FY 2023Yearly · 2023-12-31ProductSYMDEKOSYMKEVI123,000,000USD0000875320-24-000062
    FY 2023Yearly · 2023-12-31ProductTRIKAFTAKAFTRIO8,944,700,000USD0000875320-24-000062
    Q3 2023Quarterly · 2023-09-30ProductKalydeco112,800,000USD0000875320-23-000031
    Q3 2023Quarterly · 2023-09-30ProductORKAMBI63,000,000USD0000875320-23-000031
    Q3 2023Quarterly · 2023-09-30ProductSYMDEKOSYMKEVI33,400,000USD0000875320-23-000031
    Q3 2023Quarterly · 2023-09-30ProductTRIKAFTAKAFTRIO2,274,300,000USD0000875320-23-000031
    Q2 2023Quarterly · 2023-06-30ProductKalydeco125,300,000USD0000875320-23-000021
    Q2 2023Quarterly · 2023-06-30ProductORKAMBI96,300,000USD0000875320-23-000021
    Q2 2023Quarterly · 2023-06-30ProductSYMDEKOSYMKEVI31,200,000USD0000875320-23-000021
    Q2 2023Quarterly · 2023-06-30ProductTRIKAFTAKAFTRIO2,240,400,000USD0000875320-23-000021
    FY 2022Yearly · 2022-12-31ProductCollaborativeand Royalty0USD0000875320-24-000062
    FY 2022Yearly · 2022-12-31ProductKalydeco553,200,000USD0000875320-24-000062
    FY 2022Yearly · 2022-12-31ProductORKAMBI510,700,000USD0000875320-24-000062
    FY 2022Yearly · 2022-12-31ProductSYMDEKOSYMKEVI180,000,000USD0000875320-24-000062
    FY 2022Yearly · 2022-12-31ProductTRIKAFTAKAFTRIO7,686,800,000USD0000875320-24-000062
    FY 2021Yearly · 2021-12-31ProductCollaborativeand Royalty1,000,000USD0000875320-24-000062
    FY 2021Yearly · 2021-12-31ProductKalydeco684,200,000USD0000875320-24-000062
    FY 2021Yearly · 2021-12-31ProductORKAMBI771,600,000USD0000875320-24-000062
    FY 2021Yearly · 2021-12-31ProductSYMDEKOSYMKEVI420,400,000USD0000875320-24-000062
    FY 2021Yearly · 2021-12-31ProductTRIKAFTAKAFTRIO5,697,200,000USD0000875320-24-000062
    FY 2020Yearly · 2020-12-31ProductCollaborativeand Royalty2,900,000USD0000875320-23-000007
    FY 2020Yearly · 2020-12-31ProductKalydeco802,900,000USD0000875320-23-000007
    FY 2020Yearly · 2020-12-31ProductORKAMBI907,500,000USD0000875320-23-000007
    FY 2020Yearly · 2020-12-31ProductSYMDEKOSYMKEVI628,600,000USD0000875320-23-000007
    FY 2020Yearly · 2020-12-31ProductTRIKAFTAKAFTRIO3,863,800,000USD0000875320-23-000007
    FY 2019Yearly · 2019-12-31ProductCollaborativeand Royalty2,100,000USD0000875320-22-000007
    FY 2019Yearly · 2019-12-31ProductKalydeco991,000,000USD0000875320-22-000007
    FY 2019Yearly · 2019-12-31ProductORKAMBI1,331,900,000USD0000875320-22-000007
    FY 2019Yearly · 2019-12-31ProductSYMDEKOSYMKEVI1,417,700,000USD0000875320-22-000007
    FY 2019Yearly · 2019-12-31ProductTRIKAFTAKAFTRIO420,100,000USD0000875320-22-000007
    FY 2018Yearly · 2018-12-31ProductCollaborativeand Royalty9,272,000USD0000875320-21-000006
    FY 2018Yearly · 2018-12-31ProductKalydeco1,007,502,000USD0000875320-21-000006
    FY 2018Yearly · 2018-12-31ProductORKAMBI1,262,166,000USD0000875320-21-000006
    FY 2018Yearly · 2018-12-31ProductSYMDEKOSYMKEVI768,657,000USD0000875320-21-000006
    FY 2018Yearly · 2018-12-31ProductTRIKAFTAKAFTRIO0USD0000875320-21-000006
    FY 2017Yearly · 2017-12-31ProductCollaborativeand Royalty323,172,000USD0000875320-20-000007
    FY 2017Yearly · 2017-12-31ProductKalydeco844,630,000USD0000875320-20-000007
    FY 2017Yearly · 2017-12-31ProductORKAMBI1,320,850,000USD0000875320-20-000007
    FY 2017Yearly · 2017-12-31ProductSYMDEKOSYMKEVI0USD0000875320-20-000007
    FY 2017Yearly · 2017-12-31ProductTRIKAFTA0USD0000875320-20-000007
    FY 2010Yearly · 2010-12-31GeographyGeography Group One0USD0000875320-13-000009
    FY 2010Yearly · 2010-12-31GeographyGeography Group Two0USD0000875320-13-000009
    FY 2010Yearly · 2010-12-31GeographyUnited States143,370,000USD0000875320-13-000009
    FY 2010Yearly · 2010-12-31GeographyXX0USD0000875320-13-000009

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.